Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Health

Jobs Lived 8 Years with Pancreatic Cancer, Steinman for 4, But It Was Steinman Who Beat the Odds. Here's Why.

80beatsBy Veronique GreenwoodOctober 7, 2011 9:14 PM

Newsletter

Sign up for our email newsletter for the latest science news

pancreatic.jpg

Steve Jobs

and new Nobelist Ralph Steinman

both died of pancreatic cancer

, a killer that's hard to spot until it's very far advanced. But fundamental differences in their diseases made Steinman's survival more miraculous than Jobs'. Katherine Harmon at Scientific American has a great explanation

of this, starting with the fact that the pancreas is made up of two different kinds of cells:

The pancreas itself is essentially two different organs, which means two distinct kinds of tissue—and two very different types of cancer, points out [Leonard Saltz, acting chief of the gastrointestinal oncology service at Memorial Sloan-Kettering Cancer Center]. The most common kind of pancreatic cancer[s] [the kind Steinman had] originate in what is known as the exocrine portion of the pancreas. This is the main mass of the organ, which makes digestive enzymes that get shuttled to the gastrointestinal tract via specialized ducts. "Scattered in that larger organ are thousands of tiny islands," Satlz explains. "These are islands of endocrine tissue," which makes hormones that are secreted into the blood. It was a cancer of these islet cells that Jobs had.

For people with Jobs' cancer, which is quite rare, survival is measured in years. For those with Steinman's cancer, it's measured in months. Steinman's survival for four years after diagnosis may be due in part to his use of experimental immunotherapies

, which were being developed by his colleagues and sometimes incorporated Steinman's own discoveries. Jobs' liver transplant to replace an organ riddled with metastases, on the other hand, may or may not have helped him, says Saltz---having to take immunosuppressants to prevent rejection of the new organ weakens the immune system's abilities to fight off the cancer. Read more at Scientific American

. Images courtesy of mattbuchanan / flickr

and Rockefeller University

    3 Free Articles Left

    Want it all? Get unlimited access when you subscribe.

    Subscribe

    Already a subscriber? Register or Log In

    Want unlimited access?

    Subscribe today and save 70%

    Subscribe

    Already a subscriber? Register or Log In